| Literature DB >> 26536867 |
Alexis Pillsbury1, Patrick Cashman, Alan Leeb, Annette Regan, Darren Westphal, Tom Snelling, Christopher Blyth, Nigel Crawford, Nicholas Wood, Kristine Macartney.
Abstract
Increased febrile reactions in Australian children from one influenza vaccine brand in 2010 diminished confidence in influenza immunisation, highlighting the need for improved vaccine safety surveillance. AusVaxSafety, a national vaccine safety surveillance system collected adverse events in young children for 2015 influenza vaccine brands in real time through parent/carer reports via SMS/email. Weekly cumulative data on 3,340 children demonstrated low rates of fever (4.4%) and medical attendance (1.1%). Fever was more frequent with concomitant vaccination.Entities:
Keywords: Australia; Influenza; active surveillance; vaccine safety
Mesh:
Substances:
Year: 2015 PMID: 26536867 DOI: 10.2807/1560-7917.ES.2015.20.43.30050
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X